Surgery Partners, Inc. (SGRY)
USD 23.08
(2.9%)
USD 23.08
(2.9%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -11.9 Million USD | -113.68% |
| 2022 | 87 Million USD | 23.06% |
| 2021 | 70.7 Million USD | 5338.46% |
| 2020 | 1.3 Million USD | -97.18% |
| 2019 | 46.1 Million USD | 122.41% |
| 2018 | -205.7 Million USD | -288.23% |
| 2017 | -52.98 Million USD | -660.51% |
| 2016 | 9.45 Million USD | 561.51% |
| 2015 | 1.42 Million USD | 102.17% |
| 2014 | -65.89 Million USD | -627.18% |
| 2013 | -9.06 Million USD | -572.96% |
| 2012 | 1.91 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -15.5 Million USD | -25.0% |
| 2024 Q1 | -12.4 Million USD | -1140.0% |
| 2023 Q2 | 18.9 Million USD | 1475.0% |
| 2023 Q1 | 1.2 Million USD | -94.85% |
| 2023 FY | -11.9 Million USD | -113.68% |
| 2023 Q4 | -1 Million USD | -102.79% |
| 2023 Q3 | 35.9 Million USD | 89.95% |
| 2022 Q3 | -25 Million USD | -263.4% |
| 2022 Q2 | 15.3 Million USD | -64.25% |
| 2022 Q4 | 23.3 Million USD | 193.2% |
| 2022 FY | 87 Million USD | 23.06% |
| 2022 Q1 | 42.8 Million USD | 42900.0% |
| 2021 FY | 70.7 Million USD | 5338.46% |
| 2021 Q1 | -21 Million USD | -481.82% |
| 2021 Q3 | -22.9 Million USD | 14.87% |
| 2021 Q4 | -100 Thousand USD | 99.56% |
| 2021 Q2 | -26.9 Million USD | -28.1% |
| 2020 Q3 | -61.6 Million USD | -89.54% |
| 2020 FY | 1.3 Million USD | -97.18% |
| 2020 Q1 | -27.5 Million USD | -51.1% |
| 2020 Q4 | 5.5 Million USD | 108.93% |
| 2020 Q2 | -32.5 Million USD | -18.18% |
| 2019 Q1 | -20.1 Million USD | 86.4% |
| 2019 Q4 | -18.2 Million USD | -15.92% |
| 2019 Q3 | -15.7 Million USD | 20.71% |
| 2019 Q2 | -19.8 Million USD | 1.49% |
| 2019 FY | 46.1 Million USD | 122.41% |
| 2018 Q4 | -147.74 Million USD | -604.17% |
| 2018 Q1 | -17.52 Million USD | 45.55% |
| 2018 Q2 | -19.46 Million USD | -11.08% |
| 2018 Q3 | -20.98 Million USD | -7.8% |
| 2018 FY | -205.7 Million USD | -288.23% |
| 2017 Q3 | 14.33 Million USD | 420.6% |
| 2017 FY | -52.98 Million USD | -660.51% |
| 2017 Q4 | -32.17 Million USD | -324.47% |
| 2017 Q2 | -4.47 Million USD | -62.35% |
| 2017 Q1 | -2.75 Million USD | -116.33% |
| 2016 FY | 9.45 Million USD | 561.51% |
| 2016 Q3 | -2.33 Million USD | -210.28% |
| 2016 Q4 | 16.86 Million USD | 821.21% |
| 2016 Q2 | 2.12 Million USD | 129.49% |
| 2016 Q1 | -7.19 Million USD | -142.95% |
| 2015 Q2 | -5.42 Million USD | 19.76% |
| 2015 Q1 | -6.76 Million USD | 87.54% |
| 2015 FY | 1.42 Million USD | 102.17% |
| 2015 Q3 | -3.12 Million USD | 42.46% |
| 2015 Q4 | 16.73 Million USD | 636.16% |
| 2014 Q3 | -6.9 Million USD | -967.7% |
| 2014 Q1 | -4.07 Million USD | 0.0% |
| 2014 Q2 | -647 Thousand USD | 84.14% |
| 2014 FY | -65.89 Million USD | -627.18% |
| 2014 Q4 | -54.26 Million USD | -685.52% |
| 2013 FY | -9.06 Million USD | -572.96% |
| 2012 FY | 1.91 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | -21.66 Million USD | 45.078% |
| Addus HomeCare Corporation | 62.51 Million USD | 119.035% |
| AirSculpt Technologies, Inc. | -4.47 Million USD | -165.684% |
| Amedisys, Inc. | -9.74 Million USD | -22.089% |
| Astrana Health, Inc. | 60.71 Million USD | 119.599% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | 91.154% |
| IMAC Holdings, Inc. | - USD | Infinity% |
| biote Corp. | 3.31 Million USD | 458.866% |
| Cryo-Cell International, Inc. | -9.52 Million USD | -24.978% |
| Cross Country Healthcare, Inc. | 72.63 Million USD | 116.384% |
| COMPASS Pathways plc | -118.46 Million USD | 89.955% |
| DocGo Inc. | 6.85 Million USD | 273.508% |
| The Ensign Group, Inc. | 209.39 Million USD | 105.683% |
| Healthcare Services Group, Inc. | 38.38 Million USD | 131.001% |
| InnovAge Holding Corp. | -21.33 Million USD | 44.231% |
| The Joint Corp. | -9.75 Million USD | -22.024% |
| LifeStance Health Group, Inc. | -186.26 Million USD | 93.611% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | 23.732% |
| ModivCare Inc. | -204.46 Million USD | 94.18% |
| NewGenIvf Group Limited | 130.19 Thousand USD | 9240.276% |
| Option Care Health, Inc. | 267.09 Million USD | 104.455% |
| P3 Health Partners Inc. | -57.77 Million USD | 79.402% |
| P3 Health Partners Inc. | -57.77 Million USD | 79.402% |
| The Pennant Group, Inc. | 13.37 Million USD | 188.945% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | -304.99% |
| Talkspace, Inc. | -19.18 Million USD | 37.963% |
| Talkspace, Inc. | -19.18 Million USD | 37.963% |
| The Oncology Institute, Inc. | -83.06 Million USD | 85.674% |
| The Oncology Institute, Inc. | -83.06 Million USD | 85.674% |